Article
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN - 2 Mar 2021
Benson Al B, Venook Alan P, Al-Hawary Mahmoud M, Arain Mustafa A, Chen Yi-Jen, Ciombor Kristen K, Cohen Stacey, Cooper Harry S, Deming Dustin, Farkas Linda, Garrido-Laguna Ignacio, Grem Jean L, Gunn Andrew, Hecht J Randolph, Hoffe Sarah, Hubbard Joleen, Hunt Steven, Johung Kimberly L, Kirilcuk Natalie, Krishnamurthi Smitha, Messersmith Wells A, Meyerhardt Jeffrey, Miller Eric D, Mulcahy Mary F, Nurkin Steven, Overman Michael J, Parikh Aparna, Patel Hitendra, Pedersen Katrina, Saltz Leonard, Schneider Charles, Shibata David, Skibber John M, Sofocleous Constantinos T, Stoffel Elena M, Stotsky-Himelfarb Eden, Willett Christopher G, Gregory Kristina M, Gurski Lisa A
Abstract excerpt
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section. These updates include recommendations for first-line use of checkpoint inhibitors for mCRC, that is deficient mismatch repair/microsatellite...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.